Creative Planning’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,788
| Closed | -$883K | – | 3037 |
|
|
2023
Q4 | $883K | Buy |
29,788
+9,788
| +49% | +$195K | ﹤0.01% | 1302 |
|
|
2023
Q3 | $317K | Buy |
20,000
+3,181
| +19% | +$52.9K | ﹤0.01% | 1889 |
|
|
2023
Q2 | $317K | Buy |
+16,819
| New | +$199K | ﹤0.01% | 1867 |
|
|
2021
Q4 | – | Sell |
-279,963
| Closed | -$1.59M | – | 2239 |
|
|
2021
Q3 | $1.59M | Buy |
+279,963
| New | +$1.62M | ﹤0.01% | 757 |
|
|
2020
Q1 | – | Sell |
-28,786
| Closed | -$147K | – | 2129 |
|
|
2019
Q4 | $147K | Buy |
28,786
+15,662
| +119% | +$53.2K | ﹤0.01% | 1705 |
|
|
2019
Q3 | $32K | Sell |
13,124
-1,173
| -8% | -$3.11K | ﹤0.01% | 1827 |
|
|
2019
Q2 | $31K | Sell |
14,297
-55,937
| -80% | -$132K | ﹤0.01% | 1858 |
|
|
2019
Q1 | $190K | Buy |
70,234
+33,736
| +92% | +$146K | ﹤0.01% | 1605 |
|
|
2018
Q4 | $175K | Buy |
36,498
+12,298
| +51% | +$74.6K | ﹤0.01% | 1535 |
|
|
2018
Q3 | $229K | Buy |
24,200
+19
| +0.1% | +$183 | ﹤0.01% | 1587 |
|
|
2018
Q2 | $235K | Buy |
24,181
+11,589
| +92% | +$122K | ﹤0.01% | 1531 |
|
|
2018
Q1 | $132K | Sell |
12,592
-5,158
| -29% | -$50.9K | ﹤0.01% | 1699 |
|
|
2017
Q4 | $114K | Sell |
17,750
-18,000
| -50% | -$111K | ﹤0.01% | 1711 |
|
|
2017
Q3 | $273K | Buy |
35,750
+17,638
| +97% | +$117K | ﹤0.01% | 1385 |
|
|
2017
Q2 | $129K | Sell |
18,112
-35,332
| -66% | -$162K | ﹤0.01% | 1800 |
|
|
2017
Q1 | $207K | Buy |
53,444
+28,744
| +116% | +$83.9K | ﹤0.01% | 1471 |
|
|
2016
Q4 | $50K | Sell |
24,700
-2,718
| -10% | -$5.46K | ﹤0.01% | 2395 |
|
|
2016
Q3 | $73K | Buy |
27,418
+9,142
| +50% | +$26.6K | ﹤0.01% | 2077 |
|
|
2016
Q2 | $56K | Buy |
18,276
+671
| +4% | +$4.21K | ﹤0.01% | 2065 |
|
|
2016
Q1 | $150K | Buy |
17,605
+1,158
| +7% | +$9.8K | ﹤0.01% | 1379 |
|
|
2015
Q4 | $223K | Sell |
16,447
-1,168
| -7% | -$14.4K | ﹤0.01% | 1140 |
|
|
2015
Q3 | $169K | Buy |
17,615
+2,696
| +18% | +$39.4K | ﹤0.01% | 1287 |
|
|
2015
Q2 | $215K | Buy |
14,919
+619
| +4% | +$6.8K | ﹤0.01% | 853 |
|
|
2015
Q1 | $128K | Buy |
14,300
+145
| +1% | +$1.05K | ﹤0.01% | 1443 |
|
|
2014
Q4 | $86K | Buy |
14,155
+79
| +0.6% | +$722 | ﹤0.01% | 1625 |
|
|
2014
Q3 | $149K | Buy |
14,076
+576
| +4% | +$6.51K | ﹤0.01% | 1235 |
|
|
2014
Q2 | $160K | Buy |
13,500
+471
| +4% | +$5.91K | ﹤0.01% | 1155 |
|
|
2014
Q1 | $195K | Sell |
13,029
-2,771
| -18% | -$43.7K | ﹤0.01% | 1013 |
|
|
2013
Q4 | $232K | Buy |
15,800
+12,967
| +458% | +$199K | ﹤0.01% | 800 |
|
|
2013
Q3 | $48K | Hold |
2,833
| – | – | ﹤0.01% | 1540 |
|
|
2013
Q2 | $47K | Buy |
+2,833
| New | +$45.9K | ﹤0.01% | 1423 |
|
Other funds holding IMGN
Creative Planning's IMGN Position: Q1 2024 in Review
Creative Planning sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,788 shares — an estimated $883K sold.
Creative Planning first reported a position in IMGN in Q2 2013 and held it in 31 quarters. The position peaked at $1.59M in Q3 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Creative Planning reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Creative Planning sold 29,788 Immunogen Inc shares in Q1 2024, an estimated $883K.
- Creative Planning first reported a position in Immunogen Inc in Q2 2013 and held it in 31 quarters.
- Creative Planning's Immunogen Inc position peaked at $1.59M in Q3 2021.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Creative Planning's 13F filing for Q1 2024, filed 13 May 2024.